Clinical application of expanded CD4+25+ cells

Seminars in Immunology

Volumn 18, Issue 2, 2006, Pages 78-88

  June, Carl H ^a,c   Blazar, Bruce R ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adoptive immunotherapy; Graft versus host disease; Regulatory T cell

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; ENTEROPATHY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DYSREGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFERTILITY; IPEX SYNDROME; NONHUMAN; ORGAN TRANSPLANTATION; POLYENDOCRINOPATHY; REGULATORY T LYMPHOCYTE; REVIEW; STEM CELL TRANSPLANTATION; SUPPRESSOR CELL;

ANIMALS; GRAFT VS HOST DISEASE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 32644482551     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2006.01.006     Document Type: Review

References (174)

1. S. Sakaguchi, N. Sakaguchi, J. Shimizu, S. Yamazaki, T. Sakihama, and M. Itoh Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunol Rev 182 2001 18 32
2. B. Salomon, D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, and A. Sharpe B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes Immunity 12 2000 431 440
3. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
4. P.A. Taylor, R.J. Noelle, and B.R. Blazar CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade J Exp Med 193 2001 1311 1318
5. P.A. Taylor, C.J. Lees, and B.R. Blazar The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality Blood 99 2002 3493 3499
6. K.J. Wood, and S. Sakaguchi Regulatory T cells in transplantation tolerance Nat Rev Immunol 3 2003 199 210
7. H. Jonuleit, E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, and A.H. Enk Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood J Exp Med 193 2001 1285 1294
8. S. Yamazaki, T. Iyoda, K. Tarbell, K. Olson, K. Velinzon, and K. Inaba Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells J Exp Med 198 2003 235 247
9. M.A. Gavin, S.R. Clarke, E. Negrou, A. Gallegos, and A. Rudensky Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo Nat Immunol 3 2002 33 41
10. T.R. Malek, A. Yu, V. Vincek, P. Scibelli, and L. Kong CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2 Immunity 17 2002 167 178
11. W.R. Godfrey, D.J. Spoden, Ying Ge, B.L. Levine, C.H. June, and B.R. Blazar In vitro expanded human CD4+CD25+ T regulatory cells markedly inhibit allogeneic dendritic cell stimulated MLR cultures Blood 104 2004 453 461
12. M.K. Levings, S. Gregori, E. Tresoldi, S. Cazzaniga, C. Bonini, and M.G. Roncarolo Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells Blood 105 2005 1162 1169
13. P. Hoffmann, R. Eder, L.A. Kunz-Schughart, R. Andreesen, and M. Edinger Large-scale in vitro expansion of polyclonal human CD4(+)CD25 high regulatory T cells Blood 104 2004 895 903
14. D. Dieckmann, H. Plottner, S. Berchtold, T. Berger, and G. Schuler Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood J Exp Med 193 2001 1303 1310
15. M.K. Levings, R. Sangregorio, and M.G. Roncarolo Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function J Exp Med 193 2001 1295 1302
16. R. Billingham, L. Brent, and P. Medawar Quantitative studies on tissue transplantation immunity: the origin, strength and duration of actively and adoptively acquired immunity Proc R Soc Biol 143 1954 58 80
17. M.E. Dudley, and S.A. Rosenberg Adoptive-cell-transfer therapy for the treatment of patients with cancer Nat Rev Cancer 3 2003 666 675
18. D.L. Porter, and C.H. June T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up! Bone Marrow Transplant 35 2005 935 942
19. N.A. Mitchison Studies on the immunological response to foreign tumor transplants in the mouse. I. The role of lymph node cells in conferring immunity by adoptive transfer J Exp Med 102 1955 157 177
20. M.T. Lotze, B.R. Line, D.J. Mathisen, and S.A. Rosenberg The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors J Immunol 125 1980 1487 1493
21. Q. Li, S.A. Furman, C.R. Bradford, and A.E. Chang Expanded tumor-reactive CD4+ T-cell responses to human cancers induced by secondary anti-CD3/anti-CD28 activation Clin Cancer Res 5 1999 461 469
22. M.V. Maus, A.K. Thomas, D. Leonard, D. Allman, K. Schlienger, and J.L. Riley Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T cell receptor, CD28 and 4-1BB Nat Biotechnol 20 2002 143 148
23. S. Shu, T. Chou, and S.A. Rosenberg In vitro sensitization and expansion with viable tumor cells and Il-2 in the generation of specific therapeutic effector cells J Immunol 136 1986 3891 3898
24. M. Sadelain, I. Riviere, and R. Brentjens Targeting tumours with genetically enhanced T lymphocytes Nat Rev Cancer 3 2003 35 45
25. G. Gross, T. Waks, and Z. Eshhar Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity Proc Natl Acad Sci USA 86 1989 10024 10028
26. S.R. Riddell, K.S. Watanabe, J.M. Goodrich, C.R. Li, M.E. Agha, and P.D. Greenberg Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones Science 257 1992 238 241
27. S.A. Rosenberg, P. Aebersold, K. Cornetta, A. Kasid, R.A. Morgan, and R. Moen Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction N Engl J Med 323 1990 570 578
28. H.E. Heslop, C.Y. Ng, C. Li, C.A. Smith, S.K. Loftin, and R.A. Krance Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes Nat Med 2 1996 551 555
29. G.G. Laport, B.L. Levine, E.A. Stadtmauer, S.J. Schuster, S.M. Luger, and S. Grupp Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation Blood 102 2003 2004 2013
30. B.L. Levine, W.B. Bernstein, N.E. Aronson, K. Schlienger, J. Cotte, and S. Perfetto Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection Nat Med 8 2002 47 53
31. A. Mazumder, T.J. Eberlein, E.A. Grimm, D.J. Wilson, A.M. Keenan, and R. Aamodt Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells Cancer 53 1984 896 905
32. M. Feuerer, P. Beckhove, L. Bai, E.F. Solomayer, G. Bastert, and I.J. Diel Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow Nat Med 7 2001 452 458
33. C. Germeau, W. Ma, F. Schiavetti, C. Lurquin, E. Henry, and N. Vigneron High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens J Exp Med 201 2005 241 248
34. E.M. Hersh, and J.J. Oppenheim Impaired in vitro lymphocyte transformation in Hodgkin's disease N Engl J Med 273 1965 1006 1012
35. S. Broder, and T.A. Waldmann The suppressor-cell network in cancer (second of two parts) N Engl J Med 299 1978 1335 1341
36. S. Broder, and T.A. Waldmann The suppressor-cell network in cancer (first of two parts) N Engl J Med 299 1978 1281 1284
37. S. Miescher, T.L. Whiteside, S. Carrel, and V. von Fliedner Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes J Immunol 136 1986 1899 1907
38. I. Yoshino, T. Yano, M. Murata, T. Ishida, K. Sugimachi, and G. Kimura Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor Cancer Res 52 1992 775 781
39. J.H. Finke, A.H. Zea, J. Stanley, D.L. Longo, H. Mizoguchi, and R.R. Tubbs Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma Cancer Res 53 1993 5613 5616
40. T.L. Whiteside Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention Semin Cancer Biol 2005 [Epub ahead of print]
41. W. Dummer, A.G. Niethammer, R. Baccala, B.R. Lawson, N. Wagner, and R.A. Reisfeld T cell homeostatic proliferation elicits effective antitumor autoimmunity J Clin Invest 110 2002 185 192
42. M.E. Dudley, J.R. Wunderlich, J.C. Yang, R.M. Sherry, S.L. Topalian, and N.P. Restifo Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma J Clin Oncol 23 2005 2346 2357
43. A. Rapoport, E.A. Stadtmauer, N. Aqui, A. Badros, J. Cotte, and L. Chrisley Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer Nat Med 11 2005 1230 1237
44. H. Yeh, and C.H. June Use of cell-based therapies for modification of host immune responses Dev Biol 112 2003 99 104
45. E. Macy, K. Bulpitt, R.E. Champlin, and A. Saxon Anaphylaxis to infusion of autologous bone marrow: an apparent reaction to self, mediated by IgE antibody to bovine serum albumin J Allergy Clin Immunol 83 1989 871 875
46. T.A. Selvaggi, R.E. Walker, and T.A. Fleisher Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions Blood 89 1997 776 779
47. L. Tuschong, S.L. Soenen, R.M. Blaese, F. Candotti, and L.M. Muul Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy Hum Gene Ther 13 2002 1605 1610
48. C.H. Lamers, J.W. Gratama, S.O. Warnaar, G. Stoter, and R.L. Bolhuis Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytes Int J Cancer 60 1995 450 457
49. J.A. Thompson, R.A. Figlin, C. Sifri-Steele, R.J. Berenson, and M.W. Frohlich A phase I trial of CD3/CD28-activated T cells (Xcellerated T cells) and interleukin-2 in patients with metastatic renal cell carcinoma Clin Cancer Res 9 2003 3562 3570
50. S.R. Riddell, M. Elliott, D.A. Lewinsohn, M.J. Gilbert, L. Wilson, and S.A. Manley T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients Nat Med 2 1996 216 223
51. R.B. Effros, and G. Pawelec Replicative senescence of T cells: does the Hayflick limit lead to immune exhaustion? Immunol Today 18 1997 450 454
52. M.H. Linskens, C.B. Harley, M.D. West, J. Campisi, and L. Hayflick Replicative senescence and cell death Science 267 1995 17
53. N.-P. Weng, L.D. Palmer, B.L. Levine, H.C. Lane, C.H. June, and R.J. Hodes Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging Immunol Rev 160 1997 43 54
54. N.R. Forsyth, W.E. Wright, and J.W. Shay Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again Differentiation 69 2002 188 197
55. N-P. Weng, B.L. Levine, C.H. June, and R.J. Hodes Regulation of telomerase RNA template expression in human T lymphocyte development and activation J Immunol 158 1997 3215 3220
56. K.S. Hathcock, N.P. Weng, R. Merica, M.K. Jenkins, and R. Hodes Antigen-dependent regulation of telomerase activity in murine T cells J Immunol 160 1998 5702 5706
57. B.L. Levine, W. Bernstein, N. Craighead, T. Lindsten, C.B. Thompson, and C.H. June Effects of CD28 costimulation on long term proliferation of CD4+ T cells in the absence of exogenous feeder cells J Immunol 159 1997 5921 5930
58. G. Pawelec, A. Rehbein, K. Haehnel, A. Merl, and M. Adibzadeh Human T-cell clones in long-term culture as a model of immunosenescence Immunol Rev 160 1997 31 42 31-42
59. N.-P. Weng, B.L. Levine, C.H. June, and R.J. Hodes Human naive and memory T lymphocytes differ in telomeric length and replicative potential Proc Natl Acad Sci USA 92 1995 11091 11094
60. R.M. Luiten, J. Pene, H. Yssel, and H. Spits Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis Blood 101 2003 4512 4519
61. K.A. Kasow, X. Chen, J. Knowles, D. Wichlan, R. Handgretinger, and J.M. Riberdy Human CD4+CD25+ regulatory T cells share equally complex and comparable repertoires with CD4+CD25- counterparts J Immunol 172 2004 6123 6128
62. J. Zhou, X. Shen, J. Huang, R.J. Hodes, S.A. Rosenberg, and P.F. Robbins Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy J Immunol 175 2005 7046 7052
63. M.J. Bevan Helping the CD8(+) T-cell response Nat Rev Immunol 4 2004 595 602
64. C. Yee, J.A. Thompson, D. Byrd, S.R. Riddell, P. Roche, and E. Celis T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells Proc Natl Acad Sci USA 99 2002 16168 16173
65. R.T. Mitsuyasu, P.A. Anton, S.G. Deeks, D.T. Scadden, E. Connick, and M.T. Downs Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects Blood 96 2000 785 793
66. E.A. Walter, P.D. Greenberg, M.J. Gilbert, R.J. Finch, K.S. Watanabe, and E.D. Thomas Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor N Engl J Med 333 1995 1038 1044
67. R.E. Walker, C.M. Bechtel, V. Natarajan, M. Baseler, K.M. Hege, and J.A. Metcalf Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection Blood 96 2000 467 474
68. A.L. Bayer, A. Yu, D. Adeegbe, and T.R. Malek Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period J Exp Med 201 2005 769 777
69. R. Setoguchi, S. Hori, T. Takahashi, and S. Sakaguchi Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization J Exp Med 201 2005 723 735
70. N. Bosco, F. Agenes, and R. Ceredig Effects of increasing IL-7 availability on lymphocytes during and after lymphopenia-induced proliferation J Immunol 175 2005 162 170
71. Q. Tang, K.J. Henriksen, M. Bi, E.B. Finger, G. Szot, and J. Ye In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes J Exp Med 199 2004 1455 1465
72. K.E. Earle, Q. Tang, X. Zhou, W. Liu, S. Zhu, and M.L. Bonyhadi In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation Clin Immunol 115 2005 3 9
73. S. Fisson, G. Darrasse-Jeze, E. Litvinova, F. Septier, D. Klatzmann, and R. Liblau Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state J Exp Med 198 2003 737 746
74. S. Huber, C. Schramm, H.A. Lehr, A. Mann, S. Schmitt, and C. Becker Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells J Immunol 173 2004 6526 6531
75. C. Kemper, A.C. Chan, J.M. Green, K.A. Brett, K.M. Murphy, and J.P. Atkinson Activation of human CD4(+) cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype Nature 421 2003 388 392
76. N.K. Damle, J.A. Hansen, R.A. Good, and S. Gupta Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction Proc Natl Acad Sci USA 78 1981 5096 5098
77. C.C. Chang, R. Ciubotariu, J.S. Manavalan, J. Yuan, A.I. Colovai, and F. Piazza Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4 Nat Immunol 3 2002 237 243
78. G. Filaci, M. Fravega, S. Negrini, F. Procopio, D. Fenoglio, and M. Rizzi Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function Hum Immunol 65 2004 142 156
79. W.J. Grossman, J.W. Verbsky, W. Barchet, M. Colonna, J.P. Atkinson, and T.J. Ley Human T regulatory cells can use the perforin pathway to cause autologous target cell death Immunity 21 2004 589 601
80. C.T. Huang, C.J. Workman, D. Flies, X. Pan, A.L. Marson, and G. Zhou Role of LAG-3 in regulatory T cells Immunity 21 2004 503 513
81. J.L. Cohen, A. Trenado, D. Vasey, D. Klatzmann, and B.L. Salomon CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease J Exp Med 196 2002 401 406
82. P. Hoffmann, J. Ermann, M. Edinger, C.G. Fathman, and S. Strober Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J Exp Med 196 2002 389 399
83. A.M. Hanash, and R.B. Levy Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation Blood 105 2005 1828 1836
84. O. Joffre, N. Gorsse, P. Romagnoli, D. Hudrisier, and J.P. van Meerwijk Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes Blood 103 2004 4216 4221
85. P.A. Taylor, A. Panoskaltsis-Mortari, J.M. Swedin, P.J. Lucas, R.E. Gress, and B.L. Levine l-Selectin(hi) but not the l-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection Blood 104 2004 3804 3812
86. A. Trenado, F. Charlotte, S. Fisson, M. Yagello, D. Klatzmann, and B.L. Salomon Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia J Clin Invest 112 2003 1688 1696
87. M. Edinger, P. Hoffmann, J. Ermann, K. Drago, C.G. Fathman, and S. Strober CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation Nat Med 9 2003 1144 1150
88. S.C. Jones, G.F. Murphy, and R. Korngold Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response Biol Blood Marrow Transplant 9 2003 243 256
89. H. Jonuleit, E. Schmitt, H. Kakirman, M. Stassen, J. Knop, and A.H. Enk Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells J Exp Med 196 2002 255 260
90. R. Storb, H.J. Deeg, J. Whitehead, F. Appelbaum, P. Beatty, and W. Bensinger Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia N Engl J Med 314 1986 729 735
91. M. Battaglia, A. Stabilini, and M.G. Roncarolo Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells Blood 105 2005 4743 4748
92. J.J. Coenen, H.J. Koenen, E.V. Rijssen, L.B. Hilbrands, and I. Joosten Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells Blood 2005
93. S. Sakaguchi Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531 562
94. E. Gambineri, T.R. Torgerson, and H.D. Ochs Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis Curr Opin Rheumatol 15 2003 430 435
95. S.G. Zheng, J.H. Wang, M.N. Koss, F. Quismorio Jr., J.D. Gray, and D.A. Horwitz CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome J Immunol 172 2004 1531 1539
96. A.P. Kohm, P.A. Carpentier, H.A. Anger, and S.D. Miller Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis J Immunol 169 2002 4712 4716
97. C. Mottet, H.H. Uhlig, and F. Powrie Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells J Immunol 170 2003 3939 3943
98. K.V. Tarbell, S. Yamazaki, K. Olson, P. Toy, and R.M. Steinman CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes J Exp Med 199 2004 1467 1477
99. D. Lundsgaard, T.L. Holm, L. Hornum, and H. Markholst In vivo control of diabetogenic T-cells by regulatory CD4+CD25+ T-cells expressing Foxp3 Diabetes 54 2005 1040 1047
100. K. Fujio, A. Okamoto, H. Tahara, M. Abe, Y. Jiang, and T. Kitamura Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease J Immunol 173 2004 2118 2125
101. V. Viglietta, C. Baecher-Allan, H.L. Weiner, and D.A. Hafler Loss of functional suppression by CD4(+)CD25(+) regulatory T cells in patients with multiple sclerosis J Exp Med 199 2004 971 979
102. M.R. Ehrenstein, J.G. Evans, A. Singh, S. Moore, G. Warnes, and D.A. Isenberg Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy J Exp Med 200 2004 277 285
103. M.A. Kriegel, T. Lohmann, C. Gabler, N. Blank, J.R. Kalden, and H.M. Lorenz Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II J Exp Med 199 2004 1285 1291
104. S. Lindley, C.M. Dayan, A. Bishop, B.O. Roep, M. Peakman, and T.I. Tree Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes Diabetes 54 2005 92 99
105. C. Veldman, A. Hohne, D. Dieckmann, G. Schuler, and M. Hertl Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris J Immunol 172 2004 6468 6475
106. E. Nishimura, T. Sakihama, R. Setoguchi, K. Tanaka, and S. Sakaguchi Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells Int Immunol 16 2004 1189 1201
107. X.X. Zheng, A. Sanchez-Fueyo, M. Sho, C. Domenig, M.H. Sayegh, and T.B. Strom Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance Immunity 19 2003 503 514
108. J.C. Hong, and B.D. Kahan Immunosuppressive agents in organ transplantation: past, present, and future Semin Nephrol 20 2000 108 125
109. A. Bushell, E. Jones, A. Gallimore, and K. Wood The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen J Immunol 174 2005 3290 3297
110. L. Graca, S. Thompson, C.Y. Lin, E. Adams, S.P. Cobbold, and H. Waldmann Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance J Immunol 168 2002 5558 5565
111. L. Graca, S.P. Cobbold, and H. Waldmann Identification of regulatory T cells in tolerated allografts J Exp Med 195 2002 1641 1646
112. J.R. Torrealba, M. Katayama, J.H. Fechner Jr., E. Jankowska-Gan, S. Kusaka, and Q. Xu Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates J Immunol 172 2004 5753 5764
113. S. Jiang, O. Herrera, and R.I. Lechler New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance Curr Opin Immunol 16 2004 550 557
114. A.L. Mellor, and D.H. Munn Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression Annu Rev Immunol 18 2000 367 391
115. V.R. Aluvihare, M. Kallikourdis, and A.G. Betz Regulatory T cells mediate maternal tolerance to the fetus Nat Immunol 5 2004 266 271
116. L.P. Jin, D.J. Li, J.P. Zhang, M.Y. Wang, X.Y. Zhu, and Y. Zhu Adoptive transfer of paternal antigen-hyporesponsive T cells induces maternal tolerance to the allogeneic fetus in abortion-prone matings J Immunol 173 2004 3612 3619
117. W.F. Ng, P.J. Duggan, F. Ponchel, G. Matarese, G. Lombardi, and A.D. Edwards Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells Blood 98 2001 2736 2744
118. W.R. Godfrey, D.J. Spoden, Y.G. Ge, S.R. Baker, B. Liu, and B.L. Levine Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function Blood 105 2005 750 758
119. L. Li, W.R. Godfrey, S.B. Porter, Y. Ge, C.H. June, and B.R. Blazar CD4+CD25+ regulatory T-cell lines from human cord blood have molecular properties of T-cell anergy Blood 106 2005 3068 3073
120. R.H. Yonemoto, and P.I. Terasaki Cancer immunotherapy with HLA-compatible thoracic duct lymphocyte transplantation. A preliminary report Cancer 30 1972 1438 1443
121. L.A. Stephens, and D. Mason CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations J Immunol 165 2000 3105 3110
122. H. Jonuleit, E. Schmitt, G. Schuler, J. Knop, and A.H. Enk Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells J Exp Med 192 2000 1213 1222
123. E.A. Moseman, X. Liang, A.J. Dawson, A. Panoskaltsis-Mortari, A.M. Krieg, and Y.J. Liu Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells J Immunol 173 2004 4433 4442
124. J. Machen, J. Harnaha, R. Lakomy, A. Styche, M. Trucco, and N. Giannoukakis Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells J Immunol 173 2004 4331 4341
125. M.G. Roncarolo, M.K. Levings, and C. Traversari Differentiation of T regulatory cells by immature dendritic cells J Exp Med 193 2001 F5 F9
126. M.R. Walker, B.D. Carson, G.T. Nepom, S.F. Ziegler, and J.H. Buckner De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells Proc Natl Acad Sci USA 102 2005 4103 4108
127. E.L. Masteller, M.R. Warner, Q. Tang, K.V. Tarbell, H. McDevitt, and J.A. Bluestone Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice J Immunol 175 2005 3053 3059
128. I. Takeda, S. Ine, N. Killeen, L.C. Ndhlovu, K. Murata, and S. Satomi Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells J Immunol 172 2004 3580 3589
129. B. Valzasina, C. Guiducci, H. Dislich, N. Killeen, A.D. Weinberg, and M.P. Colombo Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR Blood 105 2005 2845 2851
130. B.K. Choi, J.S. Bae, E.M. Choi, W.J. Kang, S. Sakaguchi, and D.S. Vinay 4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells J Leukoc Biol 75 2004 785 791
131. G.F. Hoyne, R. Le, I. Corsin-Jimenez, M. Tan, K. Dunne, and J. Forsyth Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells Int Immunol 12 2000 177 185
132. S. Vigouroux, E. Yvon, H.J. Wagner, E. Biagi, G. Dotti, and U. Sili Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes J Virol 77 2003 10872 10880
133. E.S. Yvon, S. Vigouroux, R.F. Rousseau, E. Biagi, P. Amrolia, and G. Dotti Overexpression of the Notch ligand, jagged-1, induces alloantigen-specific human regulatory T cells Blood 102 2003 3815 3821
134. R.M. Steinman, D. Hawiger, and M.C. Nussenzweig Tolerogenic dendritic cells Annu Rev Immunol 21 2003 685 711 685-711
135. R. Walker, D.J. Kasprowicz, V.H. Gersuk, A. Benard, M. Van Landeghen, and J.H. Buckner Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells J Clin Invest 112 2003 1437 1443
136. K.C. Herold, J.B. Burton, F. Francois, E. Poumian-Ruiz, M. Glandt, and J.A. Bluestone Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala) J Clin Invest 111 2003 409 418
137. C.H. Lin, and T. Hunig Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist Eur J Immunol 33 2003 626 638
138. W.F. Rigby, T. Stacy, and M.W. Fanger Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol) J Clin Invest 74 1984 1451 1455
139. G. Vanham, J.L. Ceuppens, and R. Bouillon T lymphocytes and their CD4 subset are direct targets for the inhibitory effect of calcitriol Cell Immunol 124 1989 320 333
140. S. Gregori, M. Casorati, S. Amuchastegui, S. Smiroldo, A.M. Davalli, and L. Adorini Regulatory T cells induced by 1 alpha, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance J Immunol 167 2001 1945 1953
141. M.J. Polanczyk, B.D. Carson, S. Subramanian, M. Afentoulis, A.A. Vandenbark, and S.F. Ziegler Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment J Immunol 173 2004 2227 2230
142. S. Yamagiwa, J.D. Gray, S. Hashimoto, and D.A. Horwitz A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood J Immunol 166 2001 7282 7289
143. S.G. Zheng, J.D. Gray, K. Ohtsuka, S. Yamagiwa, and D.A. Horwitz Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors J Immunol 169 2002 4183 4189
144. Q. Tang, E.K. Boden, K.J. Henriksen, H. Bour-Jordan, M. Bi, and J.A. Bluestone Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function Eur J Immunol 34 2004 2996 3005
145. M.L. Chen, M.J. Pittet, L. Gorelik, R.A. Flavell, R. Weissleder, and B.H. von Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo Proc Natl Acad Sci USA 102 2005 419 424
146. L. Fahlen, S. Read, L. Gorelik, S.D. Hurst, R.L. Coffman, and R.A. Flavell T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells J Exp Med 201 2005 737 746
147. M. Mamura, W. Lee, T.J. Sullivan, A. Felici, A.L. Sowers, and J.P. Allison CD28 disruption exacerbates inflammation in Tgf-beta1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-beta1 Blood 103 2004 4594 4601
148. Y. Peng, Y. Laouar, M.O. Li, E.A. Green, and R.A. Flavell TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes Proc Natl Acad Sci USA 101 2004 4572 4577
149. M.C. Fantini, C. Becker, G. Monteleone, F. Pallone, P.R. Galle, and M.F. Neurath Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 J Immunol 172 2004 5149 5153
150. K.A. Kasow, X. Chen, J. Knowles, D. Wichlan, R. Handgretinger, and J.M. Riberdy Human CD4+CD25+ regulatory T cells share equally complex and comparable repertoires with CD4+CD25- counterparts J Immunol 172 2004 6123 6128
151. J.D. Fontenot, J.P. Rasmussen, M.A. Gavin, and A.Y. Rudensky A function for interleukin 2 in Foxp3-expressing regulatory T cells Nat Immunol 6 2005 1142 1151
152. L.M. D'Cruz, and L. Klein Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling Nat Immunol 6 2005 1152 1159
153. L.F. Lu, D.C. Gondek, Z.A. Scott, R.J. Noelle, and N.F. kappa B-inducing kinase deficiency results in the development of a subset of regulatory T cells, which shows a hyperproliferative activity upon glucocorticoid-induced TNF receptor family-related gene stimulation J Immunol 175 2005 1651 1657
154. P.E. Rao, A.L. Petrone, and P.D. Ponath Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta} J Immunol 174 2005 1446 1455
155. J. Ermann, P. Hoffmann, M. Edinger, S. Dutt, F.G. Blankenberg, and J.P. Higgins Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD Blood 105 2005 2220 2226
156. D.J. Mekala, and T.L. Geiger Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes Blood 105 2005 2090 2092
157. M. Cavazzana-Calvo, S. Hacein-Bey, B.G. de Saint, F. Gross, E. Yvon, and P. Nusbaum Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 2000 669 672
158. A. Aiuti, S. Slavin, M. Aker, F. Ficara, S. Deola, and A. Mortellaro Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning Science 296 2002 2410 2413
159. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor FOXP3 Science 299 2003 1057 1061
160. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 2003 330 336
161. K. Loser, W. Hansen, J. Apelt, S. Balkow, J. Buer, and S. Beissert In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity Gene Ther 12 2005 1294 1304
162. J.G. Chai, S.A. Xue, D. Coe, C. Addey, I. Bartok, and D. Scott Regulatory T cells, derived from naive CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance Transplantation 79 2005 1310 1316
163. E. Jaeckel, B.H. von, and M.P. Manns Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes Diabetes 54 2005 306 310
164. K. Oswald-Richter, S.M. Grill, N. Shariat, M. Leelawong, M.S. Sundrud, and D.W. Haas HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells Plos Biol 2 2004 955 966
165. H. Yagi, T. Nomura, K. Nakamura, S. Yamazaki, T. Kitawaki, and S. Hori Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells Int Immunol 16 2004 1643 1656
166. S.E. Allan, L. Passerini, R. Bacchetta, N. Crellin, M. Dai, and P.C. Orban The role of 2 FOXP3 isoforms in the generation of human CD4 Tregs J Clin Invest 115 2005 3276 3284
167. C. Baecher-Allan, J.A. Brown, G.J. Freeman, and D.A. Hafler CD4+CD25high regulatory cells in human peripheral blood J Immunol 167 2001 1245 1253
168. H. Einsele, E. Roosnek, N. Rufer, C. Sinzger, S. Riegler, and J. Loffler Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy Blood 99 2002 3916 3922
169. A.M. Thornton, and E.M. Shevach Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen non-specific J Immunol 164 2000 183 190
170. E.Y. Woo, C.S. Chu, T.J. Goletz, K. Schlienger, G. Coukos, and S.C. Rubin Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non small cell lung cancer and late-stage ovarian cancer Cancer Res 61 2001 4766 4772
171. W. Zou Immunosuppressive networks in the tumour environment and their therapeutic relevance Nat Rev Cancer 5 2005 263 274
172. P.M. Bolton, A.M. Mander, J.M. Davidson, S.L. James, R.G. Newcombe, and L.E. Hughes Cellular immunity in cancer: comparison of delayed hypersensitivity skin tests in three common cancers Br Med J 3 1975 18 20
173. D. Berd, H.C. Maguire Jr., and M.J. Mastrangelo Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide Cancer Res 46 1986 2572 2577
174. J.S. Miller, J. Curtsinger, M. Berthold, K. Malvey, R.L. Bliss, and C.T. Le Diminished neo-antigen response to keyhole limpet hemocyanin (KLH) vaccines in patients after treatment with chemotherapy or hematopoietic cell transplantation Clin Immunol 117 2005 144 151